Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury.
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
Diagnosing neuromyelitis optica.
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.
Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria.
Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis.
Risk evaluation and monitoring in multiple sclerosis therapeutics.
Multiple sclerosis is associated with psoriasis. A case-control study.
Exploring the Role of Nerve Growth Factorin Multiple Sclerosis: Implications in Myelin Repair.
Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.
Aquaporin-4 autoimmunity.
Improving communication with multiple sclerosis patients.
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
Aging-associated changes in motor axon voltage-gated Na(+) channel function in mice.
Clinical studies on the efficacy and safety of Padma 28, a complex herbal formulation from Tibetan medicine: an overview.
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
Living with the unexplained: Coping, distress, and depression among women with chronic fatigue syndrome (CFS) and/or fibromyalgia comparedto an autoimmune disorder.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
[Vitamin D in Multiple Sclerosis].
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Pages
« first
‹ previous
…
428
429
430
431
432
433
434
435
436
…
next ›
last »